Clinical trial
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00416650
Study timeline
Study start (unknown)2002-07-01Date precision: month
Registry last updated2013-04-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
erlotinib hydrochlorideDRUG · verified · RxNorm: erlotinib hydrochloride
Sponsors & collaborators
Vanderbilt-Ingram Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00416650 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.